关注
Piia Bartoš
Piia Bartoš
其他姓名Piia Kokkonen
未知所在单位机构
在 uef.fi 的电子邮件经过验证
标题
引用次数
引用次数
年份
CAVER Analyst 2.0: analysis and visualization of channels and tunnels in protein structures and molecular dynamics trajectories
A Jurcik, D Bednar, J Byska, SM Marques, K Furmanova, L Daniel, ...
Bioinformatics 34 (20), 3586-3588, 2018
3022018
Caver Web 1.0: identification of tunnels and channels in proteins and analysis of ligand transport
J Stourac, O Vavra, P Kokkonen, J Filipovic, G Pinto, J Brezovsky, ...
Nucleic acids research 47 (W1), W414-W422, 2019
1982019
Engineering enzyme access tunnels
P Kokkonen, D Bednar, G Pinto, Z Prokop, J Damborsky
Biotechnology advances 37 (6), 107386, 2019
1642019
Transcription and translation inhibitors in cancer treatment
N Laham-Karam, GP Pinto, A Poso, P Kokkonen
Frontiers in Chemistry 8, 276, 2020
762020
Studying SIRT6 regulation using H3K56 based substrate and small molecules
P Kokkonen, M Rahnasto-Rilla, P Mellini, E Jarho, M Lahtela-Kakkonen, ...
European Journal of Pharmaceutical Sciences 63, 71-76, 2014
612014
Substrate inhibition by the blockage of product release and its control by tunnel engineering
P Kokkonen, A Beier, S Mazurenko, J Damborsky, D Bednar, Z Prokop
RSC chemical biology 2 (2), 645-655, 2021
592021
Peptides and pseudopeptides as SIRT6 deacetylation inhibitors
P Kokkonen, M Rahnasto-Rilla, PH Kiviranta, T Huhtiniemi, T Laitinen, ...
ACS Medicinal Chemistry Letters 3 (12), 969-974, 2012
412012
Exploring mechanism of enzyme catalysis by on-chip transient kinetics coupled with global data analysis and molecular modeling
D Hess, V Dockalova, P Kokkonen, D Bednar, J Damborsky, A DeMello, ...
Chem 7 (4), 1066-1079, 2021
312021
Molecular gating of an engineered enzyme captured in real time
P Kokkonen, J Sykora, Z Prokop, A Ghose, D Bednar, M Amaro, ...
Journal of the American Chemical Society 140 (51), 17999-18008, 2018
312018
Virtual screening approach of sirtuin inhibitors results in two new scaffolds
P Kokkonen, T Kokkola, T Suuronen, A Poso, E Jarho, ...
European Journal of Pharmaceutical Sciences 76, 27-32, 2015
232015
The impact of tunnel mutations on enzymatic catalysis depends on the tunnel-substrate complementarity and the rate-limiting step
P Kokkonen, M Slanska, V Dockalova, GP Pinto, EM Sánchez-Carnerero, ...
Computational and Structural Biotechnology Journal 18, 805-813, 2020
202020
Structure of POPC lipid bilayers in OPLS3e force field
M Kurki, A Poso, P Bartos, MS Miettinen
Journal of Chemical Information and Modeling 62 (24), 6462-6474, 2022
172022
Conformational changes allow processing of bulky substrates by a haloalkane dehalogenase with a small and buried active site
P Kokkonen, D Bednar, V Dockalova, Z Prokop, J Damborsky
Journal of Biological Chemistry 293 (29), 11505-11512, 2018
142018
Structure-function relationships and engineering of haloalkane dehalogenases
P Kokkonen, T Koudelakova, R Chaloupkova, L Daniel, Z Prokop, ...
Aerobic utilization of hydrocarbons, oils and lipids. Cham: Springer …, 2017
132017
Quantitative insights for the design of substrate-based SIRT1 inhibitors
P Kokkonen, P Mellini, O Nyrhilä, M Rahnasto-Rilla, T Suuronen, ...
European Journal of Pharmaceutical Sciences 59, 12-19, 2014
102014
Direct pathway cloning and expression of the radiosumin biosynthetic gene cluster
X Ouyang, PM D'Agostino, M Wahlsten, E Delbaje, J Jokela, P Permi, ...
Organic & Biomolecular Chemistry 21 (23), 4893-4908, 2023
72023
Follistatin-like 1 and its paralogs in heart development and cardiovascular disease
M Horak, DL Fairweather, P Kokkonen, D Bednar, J Bienertova-Vasku
Heart failure reviews 27 (6), 2251-2265, 2022
72022
RNA-protein complexes and force field polarizability
H Baltrukevich, P Bartos
Frontiers in Chemistry 11, 2023
12023
Studying sirtuin inhibitors with in silico and in vitro approaches
P Kokkonen
Itä-Suomen yliopisto, 2015
2015
系统目前无法执行此操作,请稍后再试。
文章 1–19